Unlocking the Therapeutic Potential of Minor Cannabinoids through In-Silico Research

Undiscovered Potential of Minor Cannabinoids
The enormous therapeutic potential of minor cannabinoids is due to their interaction with central nervous system (CNS) receptors. The effects of various cannabinoids vary depending on the receptors to which they bind. Depending on the nature of their interaction, structural biology and computational chemistry could combine to offer mechanistic insight into the following categories of minor cannabinoids interacting with GPCR: antagonists, partial agonists, inverse agonists, and agonists. In-Silico research on cannabinoids has grown significantly, and it is anticipated to move forward quickly as more GPCR structures are solved.


Scroll to Top